Articles from Biotech Financial Reports (November 1, 1998)

Title	Author	Type	Words
BIOGEN NET INCOME MORE THAN $37 MILLION FOR THIRD QUARTER.			427
GISH BIOMEDICAL REPORTS FOURTH QUARTER NET LOSS.			554
HAEMACURE REPORTS NET LOSS OF $7.15 MILLION.			729
MERIDIAN DIAGNOSTICS EXPECTS NET SALES OF $7 MILLION.			734
OCULAR SCIENCES EXPECTS NET INCOME OF $0.36 EPS FOR THIRD QTR.			239
PACIFIC BIOMETRICS REPORTS FOURTH QUARTER LOSS.			355